Interpretability and power of genome-wide association studies can be increased by imputing unobserved genotypes, using a reference panel of individuals genotyped at higher marker density. For many markers, genotypes cannot be imputed with complete certainty, and the uncertainty needs to be taken into account when testing for association with a given phenotype. In this paper, we compare currently available methods for testing association between uncertain genotypes and quantitative traits. We show that some previously described methods offer poor control of the false-positive rate (FPR), and that satisfactory performance of these methods is obtained only by using ad hoc filtering rules or by using a harsh transformation of the trait under study. We propose new methods that are based on exact maximum likelihood estimation and use a mixture model to accommodate nonnormal trait distributions when necessary. The new methods adequately control the FPR and also have equal or better power compared to all previously described methods. We provide a fast software implementation of all the methods studied here; our new method requires computation time of less than one computer-day for a typical genome-wide scan, with 2.5 M single nucleotide polymorphisms and 5000 individuals.
INTRODUCTION
Recently, genome-wide association studies (GWAS) have identified novel associations between single nucleotide polymorphisms (SNPs) and many quantitative traits (e.g. Willer and others, 2008, and references cited in Appendix A of the supplementary material available at Biostatistics online). Despite rapid technological advances in genotyping and sequencing, currently it is not practical to measure every genetic variant in samples of thousands of individuals. Therefore, any given causal variant has a low probability of being directly measured in a given study. Indeed, efficient experimental designs deliberately measure only some genetic variants because they suffice to accurately impute (or "tag") other variants (Johnson and others, 2001; Gabriel and others, 2002; Barrett and Cardon, 2006; Anderson and others, 2008) . Such imputation relies on knowledge about linkage disequilibrium (LD) between the measured and not measured variants. Recent developments in imputation methodology make use of multilocus LD patterns estimated from reference panels of individuals with very high density genotyping (International HapMap Consortium, 2007) and quantify uncertainty about the imputed genotypes probabilistically (Li and Abecasis, 2006; Servin and Stephens, 2007; Marchini and others, 2007; Lin and others, 2008; Howie and others, 2009; Li and others, 2009) .
When analyzing many phenotypes in a single random population sample, it is useful for both conceptual and practical reasons to distinguish 2 stages of the analysis. The first stage is probabilistic genotype imputation and can be performed just once for the population sample. The second stage is testing for association between imputed genotypes and a particular phenotype, which needs to be repeated for each phenotype of interest. Several studies have recently compared different methods for genotype imputation (Guan and Stephens, 2008; Pei and others, 2008; Howie and others, 2009) . Bayesian and frequentist statistical approaches to association testing have also been contrasted (Balding, 2006; Servin and Stephens, 2007; Marchini and others, 2007; Guan and Stephens, 2008; Wakefield, 2009; Stephens and Balding, 2009 ). This paper complements those studies; our focus is entirely on comparison of frequentist methods for association testing for quantitative traits.
The statistical methods studied in this paper differ in 3 major respects. First, they differ in terms of whether and how the phenotype is transformed prior to testing for association. Second, we distinguish how a method deals with uncertainty about imputed genotypes. The simpler methods carry out association tests using the most probable set of genotypes or a set of weighted average genotypes. More sophisticated methods are based on an explicit statistical model, and maximize a missing data likelihood function, which
Testing association between uncertain genotypes and quantitative traits 3 integrates over all possible states of the uncertain genotypes. The maximization can be done either by using a quadratic approximation (e.g. Marchini and others, 2007) or by using an iterative numerical method (e.g. Marchini and others, 2007; Lin and others, 2008) . Third, in any parametric statistical framework, an error distribution must be assumed. While it is common to assume a normal distribution, we show that this is an inadequate approximation when using maximum likelihood (ML) methods, for some quantitative traits of interest. We therefore propose a novel mixture model approach in which the extent of nonnormality is estimated directly from the data being analyzed.
The main objective of this paper is to study systematically the conditions under which more sophisticated methods, which incur a greater computational cost, have improved statistical performance. We provide a comparison of the computational and statistical performances of previously described methods and of novel methods proposed here. The methods compared are summarized in Table 1 . We use a real GWAS data set to make this comparison as relevant and realistic as possible.
METHODS

Phenotype and genotype data
We use phenotype and genotype data from the "Cohorte Lausannoise" (CoLaus), which has been described previously (Firmann and others, 2008) . Briefly, this cohort is a random population sample with an extensive set of phenotype measurements, 15 of which we use in this study (for details see Appendix A of the supplementary material available at Biostatistics online). Genotype data were obtained for all individuals using Affymetrix GeneChip Human Mapping 500K Arrays. Genotypes at a further ∼2 M SNPs were imputed with the methodology of Marchini and others (2007) using haplotypes and fine-scale recombination rates estimated from the HapMap CEU panel (International HapMap Consortium, 2007) . This methodology compares favorably with other state-of-the-art (Guan and Stephens, 2008; Pei and others, 2008; Howie and others, 2009 ). For measured SNPs, missing data were imputed using the same approach.
Analyses using the full cohort have variable sample sizes, from n = 5 337 to n = 5 412, due to differences in missingness across phenotypes. Many GWAS have smaller sample sizes, for example, ranging between n = 1 094 and n = 5 433 in the study of Willer and others (2008) and there is increasing interest in analyzing subgroups, for example, females less than 50 years old, constituting perhaps ∼25% of the total sample. Therefore, we constructed smaller sample sizes with n = 250, n = 500, and n = 1 000 by sampling individuals without replacement from the full CoLaus sample.
Assumptions and notation
The methods studied here all assume that the genotypes of interest have been imputed within a probabilistic framework, and that, at any given SNP, the set of possible genotypes is coded by a real valued set, for example, {0, 1, 2} for an additive model. The genotype uncertainty for the ith individual at this SNP is represented by a vector, p i = ( p i0 , p i1 , p i2 ), where p i j = Pr (X i = j|G ) is the probability that the genotype is j, given some data G . Here, the unknown genotype for the ith individual is thought of as a random variable X i and G is a generic notation for any observed data used to infer genotypes at the locus under consideration. Thus, G may include any combination of genotypes at other loci, empirical LD patterns, and measurements from noisy genotyping platforms. For further details see Appendix C of the supplementary materia available at Biostatistics online.
Given observations of a continuous phenotype y = (y 1 , . . . , y n ) , we consider association analysis in the traditional framework of the linear model is a vector of independent and identically distributed (i.i.d.) random variables with distribution F(ψ ψ ψ). We will call h(y i ) the "response variable," and we allow the function h(•) to implicitly depend on covariates and on coefficients estimated from the data. In (2.1), the genetic effect β is the parameter to be estimated and β = 0 is the null hypothesis to be tested. Other parameters, including the intercept parameter, are all elements of ψ ψ ψ, and are of only indirect interest here. The normal linear model is a special case of (2.1), where F(ψ ψ ψ) is a normal distribution with mean μ = ψ 1 and variance σ 2 = ψ 2 . Importantly, in this work, we relax the normality assumption and allow more general forms of F(ψ ψ ψ), as described in Section 2.5 below.
Phenotype transformation
When expressed in conventional units (e.g. mmHg for blood pressure, kg/m 2 for body mass index, mM/l for serum lipids), many quantitative phenotypes are not normally distributed and they may be transformed prior to testing for association. We distinguish between the measured phenotypes (the y i ) and the derived response variables that are the h(y i ) in (2.1). In this paper, we define each vector of response variables, for the n individuals, to be the vector of residuals, after regressing a particular transformed phenotype onto a set of covariates. In applications, many factors affect the choice of transformation, including satisfying the modeling assumptions and preserving interpretability of results. We constructed a set of 22 response variables using power transformations with parameters estimated by ML (Box and Cox, 1964) and using additional subjectively chosen transformations for some phenotypes. This allows us to study the behaviors of different association testing methods, in practical scenarios where the response variables are at least approximately normally distributed ( Figure 1 panels (a) and (b); for details see Appendix A of the supplementary material available at Biostatistics online). In addition, we constructed exactly normal response variables using independent random draws from a standard normal distribution and by using a normal quantile (NQ) transformation (see Appendix A of the supplementary material available at Biostatistics online). Because NQ-transformed response variable distributions do not depend on the original phenotype distributions (unless there are tied values), in tests where we use a permuted NQtransformed response variable, we report one set of results that apply for all the phenotype distributions studied here.
Normal association testing
Many authors have previously considered association analysis assuming normally distributed errors. A relatively simple method for using uncertain genotypes is to introduce a threshold probability value, say p call , and to treat all genotypes with probabilities exceeding this threshold as if the most probable genotype had been directly observed. We will call this the "normal calling method" and use p call = 0.9 throughout this work. An alternative method (used by e.g. Mott and others, 2000; Zaykin and others, 2002; Xie and Stram, 2005; Willer and others, 2008; Guan and Stephens, 2008) is to replace each uncertain genotype X i by its expectation with respect to the vector of probabilities p i . We will call this the "normal mean method"; some other authors use the term "expected [allele] dosage method" or "expectation-substitution method". The calling and mean methods are attractive because they are computationally straightforward, and because association tests can be carried out for a rich class of models, in essentially an identical way as for measured, certain genotypes. However, because neither the calling method nor the mean genotype method explicitly take account of uncertainty about the uncertain genotypes (but see Xie and Stram, 2005) , it is natural to ask whether they are making best use of the available data. Marchini and others (2007) adopted a missing data likelihood approach, which allows many standard association analyses to be applied to imputed genotypes. In this approach, the values taken by the uncertain genotypes are the missing data (see Appendix C of the supplementary material available at Biostatistics online). For testing association using either the normal linear model or a logistic regression ) shows density estimates using a Gaussian kernel with bandwidth chosen to be optimal for estimating a normal density. The response variables are detailed in Table A .1 of the supplementary material available at Biostatistics online and are ranked here from most normal (Qnorm; blue) to least normal (SBP; red). Methods based on "normal" missing data likelihood can show severely inflated FPR, exhibited here in − log 10 QQ plots for permuted data with no real association. Panel (c) shows results for the normal ML method, and panel (d) shows results for the normal score method. In contrast, the mixture ML method never appears to have inflated FPR, as shown in panel (e). In panels (c)-(e) p-values below 10 −55 are not shown to scale. Results are overlaid for all 24 response variables, using the same colour scheme as in panels (a) and (b).
model, Marchini and others (2007, and associated software) proposed the use of a quadratic approximation around β = 0 for the log of the missing data likelihood. The resulting test for association is a classical score test (Pawitan, 2001, Chapter 9) , and the quadratic approximation provides a natural estimate and standard error for β (see Appendix D of the supplementary material available at Biostatistis online). This is closely related to score tests used in previous work, when genotype uncertainty arose in the context of haplotype phasing (e.g. Clayton, 1999; Schaid and others, 2002; Xie and Stram, 2005) and admixture mapping (Hoggart and others, 2004) . The score test proposed by Marchini and others (2007) uses the curvature of the log of the missing data likelihood (which is the observed Fisher information) to estimate the variance of the score statistic. When the normal linear model is assumed, we will call this method the "normal score method."
For the normal linear model, we show in Appendix D of the supplementary material available at Biostatistics online that the exact variance of the score statistic (which is the expected Fisher information) can be written down. The resulting test is equivalent to testing using the normal mean method described above, and so the normal mean method could rightly be called a score test (Xie and Stram, 2005) . In this paper, we will need to maintain a clear distinction, and will therefore refer to methods based on the observed Fisher information as score methods, and to methods based on expected genotypes as mean methods.
The missing data likelihood can be maximized using an iterative algorithm, such as a general purpose maximization algorithm (Press and others, 1992 , Section 10), or the expectation-maximization (EM) algorithm (Dempster and others, 1977) . This provides an exact maximum likelihood estimate (MLE) for β, and allows a likelihood ratio test (LRT) to be performed. When the normal linear model is assumed, we will call this the "normal ML method." Marchini and others (2007) proposed the use of the Newton-Raphson algorithm (Press and others, 1992 , Section 9.4) in this context but did not describe its performance and did not provide any software implementation. Lin and others (2008) developed ML for case/control phenotypes but performed genotype imputation using a relatively simple model (Marchini and Howie, 2008) . In this paper, we show that the normal ML method can be made computationally tractable for large data sets such as GWAS with thousands of individuals.
Normal mixture model for errors
To relax the assumption of the normally distributed errors, we have developed methods that use the Kcomponent normal mixture model for the error distribution F(ψ ψ ψ). This model has been studied extensively (see, e.g. Redner and Walker, 1984; Wasserman, 2000 , and references therein for details). This model can approximate a broad class of nonnormal F(ψ ψ ψ), for example, accommodating both skew and heavy tails and is also computationally convenient. It assumes that each error i in the linear model (2.1) is independently assigned to one of K mixture components according to a set of probabilities π 1 , . . . , π K . The mixture error density is
where φ(•) is the standard normal density and the kth normal component has mean μ k and variance
Note that no biological meaning needs to be attached to the mixture components; they are merely a device for modeling a distribution F(ψ ψ ψ) that is nonnormal. The mixture model assumption of (2.2) gives rise to generalizations of the normal methods described above, which we will call the (K -component) "mixture mean method," "mixture score method," and "mixture ML method." For further details see Appendix E of the supplementary material available at Biostatistics online.
To apply these mixture methods, it is necessary to choose a suitable value for K . In GWAS applications, the majority of true genetic effect sizes are small, so it is reasonable to examine the response variable distribution when trying to decide a suitable model for the error distribution. Because choosing K = 1 makes the mixture model equivalent to a simple normal model, the problem of choosing K is 8 Z. KUTALIK AND OTHERS closely related to the problem of deciding whether the response variable distribution is "close enough" to normal. A natural choice for K is a model-based estimate, which we call K , obtained by optimization using a suitable measure of goodness of fit of the K component mixture model (2.2) to the response variable distribution. In this paper, we use the Bayesian information criterion (BIC; Schwarz, 1978; O'Hagan and Forster, 2004, Section 7.24 ) to measure goodness of fit, and use BIC(K , 1) to denote the BIC for a K component model versus a simple normal model. For details see Appendix F.3 of the supplementary material available at Biostatistics online.
Comparison of methods
Comparison between competing statistical methods is most informative when we know the true status of the null hypothesis being tested or the true value of the parameter being estimated. However, for real data, these are usually not well known. We therefore perform 2 types of comparisons, both of which use the real imputed genotypes for CoLaus.
Our first set of comparisons uses synthetic response variables, which have similar distributions to the real response variables, but where we know β * (the true value of β) by construction. Each synthetic response variable was constructed from a random permutation of a real response variable. A genetic effect was added, constructed by simulating each individual genotype, X i , according to the probability vector p i , and then multiplying by β * . That is, the synthetic response variable for the ith individual is
0 with probability p i0 , 1 with probability p i1 , 2 with probability p i2
and where r = (r 1 , . . . , r n ) is a random permutation of (1, . . . , n). We reduce Monte Carlo error in our results by using an independent random permutation of the same phenotype for each SNP. For comparability across different response variable distributions, we measure β * relative to sd( ), the standard deviation of the permuted response variable that is being used as an error distribution. When comparing methods in terms of their false-positive rate (FPR), we use β * = 0, so each synthetic response variable is simply a random permutation of a real response variable. We visually summarize the results using − log 10 quantile-quantile (QQ) plots, which compare the distribution of p-values against the uniform [0, 1] distribution that is expected when the null hypothesis is true. To measure the excess FPR, we computed the fraction of SNPs for which the null hypothesis would be rejected, when the BenjaminiHochberg step-up procedure (Benjamini and Hochberg, 1995) is used to control the false discovery rate (FDR) at 0.05. This measures the point of first substantial departure from the 1:1 line in the QQ plot. Note that, as well as controlling the FDR, the Benjamini-Hochberg step-up procedure controls the family-wise error rate in the weak sense (see, e.g. Dudoit and others, 2003) , which applies in our testing scenario because the null hypothesis is true for all SNPs, and each test is independent because it uses an independently permuted phenotype. Other measures of the FPR (e.g. fraction of SNPs with p 5 × 10 −8 ) yield qualitatively similar results.
In our second set of comparisons, we computed results for real CoLaus response variables and then measured performance using the success rate of in silico replication of the most significantly associated SNPs, using published data for the same phenotypes in a different sample of individuals (Willer and others, 2008) . For details see Appendix J of the supplementary material available at Biostatistics online.
To study how the performance of different methods depends on the amount of uncertainty about imputed genotypes, we use the measure of genotype certainty r 2 , as used previously by, for example, Willer and others (2008) . For a definition of this measure and further details see de Bakker and others (2008) and Appendix G of the supplementary material available at Biostatistics online. To study how the performance of different methods depends on the response variable distribution, we use BIC(2, 1) as a measure of response variable nonnormality. More negative values of BIC(2, 1) indicate a better fit of a K = 2 component mixture compared with a simple normal model and thus greater departure from normality. For details see Section 2.5 and Appendix F.3 of the supplementary material available at Biostatistics online.
RESULTS
False-positive rates
In Figure 1 , panels (c)-(e) show QQ plots for the normal ML method, the normal score method, and the mixture ML method with K = 2. These plots used synthetic response variables where the null hypothesis is always true and illustrate our first major result: The normal score and normal ML methods can have undesirably high FPR for some response variable distributions, while the mixture ML method has zero excess FPR for all response variable distributions we have examined (Figure 1 ). In the following, we first describe how the FPR behavior differs between the normal methods and then describe the FPR behaviors of the mixture methods.
The normal calling method only shows small excess FPR (Table H .4 of the supplementary material available at Biostatistics online) and this occurs only for response variable distributions that have outlying values at 5 standard deviations from the mean. The normal mean method always has zero excess FPR and appears to be completely robust to the presence of these outliers. This is probably because the mean method always uses data from all individuals, whereas the calling method only uses data from individuals with genotype probabilities exceeding the threshold p call , which will result in smaller sample sizes for some SNPs and hence greater sensitivity to outliers. The normal score method produces excess false positives, for all response variable distributions studied here, and often with very small p-values. Figure 2 and Table H .4 of the supplementary material available at Biostatistics online show that the excess FPR increases when the sample size is smaller and also increases slightly for response variable distributions that are further from a normal distribution.
The excess FPR of the normal score method could occur either because the distribution of the score statistic is not normal, or because the observed Fisher information is a poor estimate of the variance of that distribution, or both. Testing using the normal mean method is equivalent to using the same score statistic but with an exact calculation of the variance (see Appendix D of the supplementary material available at Biostatistics online). Because the normal mean method has zero excess FPR, our results show that the excess FPR of the normal score method is caused by the use of the observed Fisher information and not by nonnormality of the score statistic distribution. Thus, the excess FPR is not a property of score tests for association with uncertain genotypes in general but is a property of the specific score test proposed by Marchini and others (2007) .
As shown in Figure 1 , the normal ML method produces excess false positives for some response variables but not others. Like the normal score method, the normal ML method shows greater FPR for response variable distributions that are further from normality. For less normal response variables, the FPR for the normal ML method is alarmingly high and is often worse than for the normal score method. However, for the normal ML method, there is an abrupt transition, such that for more normal response variables there is zero excess FPR. We note that over a broad range of sample sizes from n = 250 to n 5000, the transition between high and zero excess FPR occurs near BIC(2, 1) = 0 (Figure 2 ). Therefore, we propose BIC(2, 1) 0 as a reasonable operational definition of response variables that are "close enough" to normality for the ML method to be reliable. In Appendix F.3 of the supplementary 10 Z. KUTALIK AND OTHERS Fig. 2 . The FPR increases for response variable distributions that are further from a normal distribution. Departure from normality is measured here using BIC(2, 1); smaller values indicate greater departure from normality. The effect is extremely marked for the normal ML method (•). When plotted on the same scale, the effect is small (but formally statistically significant) for the normal score method ( ). For the normal ML method (•), the FPR is lower in small samples, while for the normal score method ( ), the FPR is slightly higher in small samples. Filtering to include only SNPs with r 2 0.3 and MAF 0.01 eliminates excess false positives for both the normal ML method (•) and the normal score method ( ) when the sample size is n 5 000 but not for smaller sample sizes. material available at Biostatistics online, we show that BIC(2, 1) is a better predictor of excess FPR than other normality measures.
For the normal score and normal ML methods, excess false positive results tend to occur for SNPs with uncertain genotypes that have low minor allele frequency (MAF), or low genotype certainty ( r 2 ), or both. This is illustrated in Figure 3 , which shows the combinations of MAF and r 2 for which false positive results are generated by the normal score method using the untransformed systolic blood pressure (SBP) response variable. When the sample size is n 5000, filtering that includes SNPs only with both MAF 0.01 and r 2 0.3 restores good calibration of the p-values, for both the normal score and the normal ML methods, for all response variable distributions considered here (Figures 2 and 3) . However, for smaller sample sizes, this filter is not sufficient to eliminate excess false positives, and both the normal score and normal ML methods have excess FPR (Figures 2 and 3) .
Motivated by the idea that the excess FPR of the normal ML method is caused by inadequacy of the normal error model, we developed mixture model-based methods that make less stringent assumptions about the error distribution (Section 2.5). In all cases, we have studied, the mixture ML method with K = 2 produces well-calibrated p-values and has zero excess FPR (Figure 1 and Table H .4 of the supplementary material available at Biostatistics online). The mixture mean method also has zero excess FPR, which is unsurprising because it is a generalization of the normal mean method, which itself already has zero excess FPR. The mixture score method, which generalizes the normal score method, does not solve the problem of elevated FPR and has a similar FPR to the normal score method.
Strategies for preventing false positives
Our results show that any one of the following strategies is sufficient to obtain well-calibrated association p-values using uncertain genotypes:
1. perform association tests using mean genotypes, 2. filter the results to exclude SNPs with low MAF and also exclude SNPs with low genotype certainty, 3. transform the phenotype so that it is sufficiently close to normality and perform association tests using the normal ML method in place of the normal score method, 4. perform association tests using the mixture ML method or mixture mean method.
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Power comparison using simulated data
Control of the FPR is necessary but not sufficient for good performance of a statistical method. Therefore, we investigated the power to test the null hypothesis β = 0 and the accuracy of estimates of β using synthetic response variables simulated under the alternative hypothesis β * = 0.
We emphasize that for the simulation scheme described in Section 2.6, we can only compare the power of different methods at a fixed nominal FPR α, which is simply the fraction of SNPs for which p α, when β * = 0. In our comparison, a method that generates small p-values at a high rate regardless of the data (i.e. a method with elevated FPR) would appear to have a high power. Therefore, we focus here on comparing methods that do not have elevated FPR. We thus exclude the normal ML method for farfrom-normal response variable distributions and exclude the mixture score method altogether. However, we retain the normal score method in our comparison because it is currently widely used.
In Section 3.1, we showed that the FPR of the normal ML method can be very high when the response variable distribution is not close to normal, and that a NQ transformation applied to any phenotype (without tied values) is sufficient to ensure that the normal ML method has good FPR control. Indeed, Servin and Stephens (2007) explicitly recommend NQ transformation in this context. We will call this approach the "NQnormal mean method" or "NQnormal ML method," according to the method used after NQ transformation. We present results for only the NQnormal mean method because these 2 methods produce indistinguishable results, but the NQnormal mean method is computationally much faster. We present no results for the "NQnormal score method" because it fails to control the FPR.
An important result is that, for the simulation scheme described in Section 2.6, the mixture ML method (with K = 2) has equal or better power than all other methods we have considered. This is true for all parameters of the simulation scheme, and for all performance measures, and is true when the performance measure is an average over any reasonable subset of SNPs. Figure 4 illustrates this result, assuming true effect size β * = 0.1sd( ), and calculating power at a fixed nominal FPR α = 10 −7 . For further results and discussion, including results for different β * and α values, and results confirming that mixture methods are superior to normal methods when the errors are drawn directly from a 2-component normal mixture, see Appendix I and Figures I12-I20 of the supplementary material available at Biostatistics online.
Performance on real data
We applied all the methods compared in Section 3.3 using real response variables derived from the serum lipid phenotypes (low density lipoprotein [LDL] , high density lipoprotein [HDL] , and triglycerides) in CoLaus. We found generally modest differences in performance when comparing results against a "truth" standard derived from analyses of the same phenotypes in independent samples (Willer and others, 2008) . These comparisons support the results seen using simulated data (Section 3.3), confirming that in real applications, mixture methods are never less powerful than normal methods, and that the combination of a simple subjective transformation with a mixture method often gives the best performance. For details see Appendix J of the supplementary material available at Biostatistics online.
DISCUSSION
Analysis of imputed genotypes can help to refine an association signal and thus come closer to identifying true causal variants. However, there are often measurable levels of uncertainty about imputed genotypes. Measurable genotype uncertainty also arises when copy number variant (CNV) genotypes are measured on microarray platforms (Colella and others, 2007) . Indeed, there is increasing interest in expressing uncertainty about all genotypes probabilistically and avoiding genotype "calling" altogether (Kang and others, 2004; Plagnol and others, 2007; Wellcome Trust Case Control Consortium, 2007; McCarthy and others, 2008) .
In this paper, we compare different methods for taking genotype uncertainty into account when performing association tests. We consider only continuous, approximately normally distributed phenotypes, and we caution that conclusions drawn from our simulation results cannot necessarily be extrapolated to binary phenotypes (although Xie and Stram, 2005, give theoretical results for generalized linear models). Although Bayesian association testing methods have recently been proposed (Balding, 2006; Servin and Stephens, 2007; Marchini and others, 2007; Guan and Stephens, 2008; Wakefield, 2009; Stephens and Balding, 2009) , in this paper, we consider only frequentist methods because they are more widely used, especially in the context of contributing results to a meta-analysis of multiple GWAS.
We find that the simple procedure of analyzing called genotypes (a.k.a analyzing "best guess" genotypes) is a poor approach. Our recommendation is that this method should never be used. On the other hand, we find that the equally simple procedure of analyzing mean genotypes (a.k.a using "expected dosages") is a good approach. In terms of power and accuracy, analyzing mean genotypes is about as 14 Z. KUTALIK AND OTHERS good as many of the more sophisticated methods studied here. In terms of controlling the FPR, analyzing mean genotypes is actually better than some of the more sophisticated methods.
The normal score method has been used for many GWAS analyses, and those analyses have contributed to large scale meta-analyses and discovery of novel associated loci. The results in this paper show that the normal score method has an elevated FPR and does not confer any advantage in power or accuracy over the normal mean method. Fortunately, the elevated FPR of the normal score method is very unlikely to have contributed false positives to published results, because meta-analysis over multiple GWAS provides partial protection against false positives generated in a single study, and because relatively stringent filtering on genotype certainty is currently common practice. Thus, the normal score method is a method that has worked well in practice, but our recommendation is that alternative methods should supersede it, at least for analysis of continuous phenotypes.
The superiority of the normal mean method over the normal score method has a straightforward explanation. The normal mean method and the normal score method are equivalent, except that the former uses the exact variance of the score statistic, whereas the latter uses an estimate (see Appendix D of the supplementary material available at Biostatistics online). Therefore, analyzing mean genotypes could rightly be called a score test (Xie and Stram, 2005) , although this does not appear to have been widely appreciated.
When the phenotype is transformed to be "close enough" to a normal distribution, the iterative numerical approach of the normal ML method achieves good control of the FPR. We cannot recommend this approach unreservedly because our operational definition of "close enough" to normal (i.e. BIC(2, 1) 0, see Section 3.1) is not guaranteed to be sufficient in general. It is clear that a given degree of departure from normality affects association tests with uncertain genotypes to a greater extent than with certain genotypes. Thus, our preferred approach is to use either the mixture mean or mixture ML method, both of which explicitly model nonnormal response variables. These methods exhibit good control of the FPR and no loss of power or accuracy in all situations where we have applied them.
Not surprisingly, poor performance of methods based on the normal missing data likelihood (i.e. the normal score and normal ML methods) is most common when there is little information about the uncertain genotypes, or when there is low MAF, or both. Filtering to exclude such SNPs from the analysis is at first sight an appealing strategy, since many false positives are eliminated, and few true positives are eliminated because there is little power to detect association with such SNPs. However, practical implementation of a filtering strategy involves making decisions about threshold values for exclusion. There is currently little consensus of opinion, for example, de Bakker and others (2008) cite studies that filter on measures of genotype certainty using cutoffs of 0.3, 0.5, and 0.8, and there is little theory or empirical data to guide such decisions. The availability of larger reference panels of resequenced genomes (e.g. from the 1000 genomes project, see Howie and others, 2009; Li and others, 2009 ) will lead to a greater proportion of imputed SNPs having either low MAF or low genotype certainty, and it is unlikely these will all be filtered and excluded in future GWAS.
The normal mean, mixture mean, and mixture ML methods for association testing make filtering unnecessary, at least for the purposes of controlling the FPR. This is desirable because filtering is inherently illogical. Filtering means that information about each SNP is being summarized by 3 numbers: the association p-value, a measure of genotype certainty such as r 2 , and the MAF. Because SNPs cannot be ranked using this summary, it cannot be a measure of statistical evidence unless further assumptions are made. Filtering can be justified for reasons that are not directly related to suppressing false positive results induced by the choice of association testing methodology. For example, filtering on MAF may help to focus on variants that explain larger fractions of heritable variation, or variants that are likely to be present in many different populations, or to exclude a class of SNPs with elevated frequency of genotyping errors. Likewise, filtering on genotype certainty is justified if there is uncertainty about the goodness of the model used for imputation. However, we believe it is desirable to separate such considerations from the assessment of the statistical evidence per se for association.
In summary, if computational cost is absolutely critical (e.g. if performing permutations, bootstrapping, or iterative model selection of multiple SNPs), then we recommend the simple and cheap normal mean method. For more general usage, we recommend the mixture model-based association testing methodology described here, and specifically the mixture ML method, on the basis that it is sometimes better and never worse than other available methods. The mixture mean method is a near-perfect substitute when there is reasonable genotype certainty (say r 2 0.3) and saves some computational effort. The 3 methods just recommended are all suitable for routine use in applications because they do not require careful choice of phenotype transformation prior to association analysis and there is reduced need for filtering and quality control of the results.
We anticipate that future work, especially that involving CNVs measured on high-throughput platforms or involving large-scale low-coverage resequencing data (e.g. Nejentsev and others, 2009) , will place greater emphasis on probabilistic representation of genotype uncertainty. Ideally, uncertainty should be propagated through all stages of an analysis, from genotype "calling," through imputation and association testing, to design of subsequent replication and fine-mapping experiments. In this context, further research on methodology for analysis of uncertain genotypes is needed.
SUPPLEMENTARY MATERIAL
Supplementary material is available at http://biostatistics.oxfordjournals.org. Software implementing the methods described here is available from http://toby.freeshell.org/software/quicktest.shtml.
